Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia

Area of Science:

• Biochemistry
• Neuroscience
• Oncology

Background:

• Chemotherapy agents like cisplatin cause frequent, dose-limiting complications such as neuropathy and cachexia.
• These side effects significantly impact cancer patient quality of life and survival.
• Ghrelin, a newly discovered hormone, possesses orexigenic and neuroprotective properties.

Purpose of the Study:

• To investigate the therapeutic potential of ghrelin in mitigating cisplatin-induced complications.
• To determine ghrelin's effects on mechanical hyperalgesia, anorexia, and cachexia.

Main Methods:

• Adult male Sprague-Dawley rats received cisplatin, ghrelin, or a combination.
• Daily measurements of food intake and body weight were recorded.
• Behavioral tests assessed mechanical and thermal sensitivity; plasma ghrelin and IGF-I levels were analyzed.

Main Results:

• Ghrelin coadministration significantly inhibited cisplatin-induced mechanical hyperalgesia, anorexia, and cachexia.
• Ghrelin prevented the cisplatin-induced decrease in plasma IGF-I levels.
• The neuroprotective effect of ghrelin on hyperalgesia correlated with preserved IGF-I levels.

Conclusions:

• Ghrelin administration shows promise for preventing or treating chemotherapy-induced neuropathy and cachexia.
• Ghrelin's ability to attenuate mechanical hyperalgesia in rats offers a model for further mechanistic studies.
• Understanding these mechanisms is crucial for managing chemotherapy-related complications.